Large-scale testing (Phase 3)Study completedNCT02667587
What this trial is testing
An Investigational Immuno-therapy Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)
Who this might be right for
Brain Neoplasms
Bristol-Myers Squibb 716